DJIA 17,778.15 0.00 0.00%
NASDAQ 4,748.40 0.00 0.00%
S&P 500 2,061.23 0.00 0.00%
market minute promo

Gilead Sciences (NASDAQ: GILD)

105.54 0.00 (0.00%)

REAL-TIME: Last trade at

Extended Hours: $105.79 $0.25 (0.24%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

GILD $105.54 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $104.48
Previous Close $105.54
Daily Range $103.66 - $105.71
52-Week Range $63.50 - $116.83
Market Cap $159.2B
P/E Ratio 18.16
Dividend (Yield) $0.00 (0.0%)
Volume 14,235,964
Average Daily Volume 15,228,366
Current FY EPS $7.91





Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary

3 Pharma Giants Growing Significantly Faster Than Pfizer, Inc.

Pfizer is a staple in most retirement and income portfolios, but investors can find stronger growth prospects in each of these three big pharmaceutical stocks.

The 2015 Calendar Of NASH Trial Catalysts IV: GENFIT And Gilead

Update: News On Gilead From The California Technology Assessment Forum

Jim Cramer's 'Mad Money' Recap: 10 Reasons We'll Have a Santa Claus Rally

Alexion's Rare Disease Model Analyzed

Biogen Idec Poised To Continue Its Stellar Run

Is it Time to Sell Gilead Sciences?

2014 Healthcare Stock Report Card: Sobek Tracks His Hits and Misses

Noteworthy ETF Outflows: OEF, GILD, GOOG, PM

Pfizer, Inc. Invests in Growth... Literally

Pfizer, Inc. pays $275 million upfront for commercialization rights to Opko Health Inc.'s promising human growth hormone drug.

See More GILD News...

GILD's Top Competitors

GILD $105.54 (0.00%)
Current stock: GILD
AMGN $168.48 (0.00%)
Current stock: AMGN
CELG $116.48 (0.00%)
Current stock: CELG
$0.00 (0.00%)
Current stock: